MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
Authors
Keywords
miR-497, Neuroblastoma, <em class=EmphasisTypeItalic >WEE1</em>, Tumor suppressor, Cisplatin
Journal
Molecular Cancer
Volume 12, Issue 1, Pages 23
Publisher
Springer Nature
Online
2013-03-26
DOI
10.1186/1476-4598-12-23
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
- (2012) J Ryan et al. BRITISH JOURNAL OF CANCER
- MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway
- (2012) Jennifer Lynch et al. CARCINOGENESIS
- Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
- (2012) Amanda Tivnan et al. PLoS One
- High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
- (2012) Gry Irene Magnussen et al. PLoS One
- MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma
- (2011) Isabella Bray et al. CANCER LETTERS
- MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2
- (2011) N H Foley et al. CELL DEATH AND DIFFERENTIATION
- Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
- (2011) D. Li et al. CLINICAL CANCER RESEARCH
- WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
- (2011) P. C. De Witt Hamer et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
- (2011) Elisa Giovannetti et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- miR-497 and miR-302b Regulate Ethanol-induced Neuronal Cell Death through BCL2 Protein and Cyclin D2
- (2011) Sanjay Yadav et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
- (2011) Wei Zhu et al. MEDICAL ONCOLOGY
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
- (2010) Shahryar E. Mir et al. CANCER CELL
- microRNAs regulate human embryonic stem cell division
- (2010) Junlin Qi et al. CELL CYCLE
- Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q- Neuroblastoma
- (2010) P. G. Buckley et al. CLINICAL CANCER RESEARCH
- Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
- (2010) Johannes H. Schulte et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
- (2010) Niamh H Foley et al. Molecular Cancer
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
- (2009) P Mestdagh et al. ONCOGENE
- Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
- (2009) Elizabeth Iorns et al. PLoS One
- Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
- (2009) Isabella Bray et al. PLoS One
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started